Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Halometasone + triclosan** is a fixed-dose topical cream combining halometasone, a potent synthetic glucocorticoid, with triclosan, a broad-spectrum antiseptic. Halometasone activates the glucocorticoid receptor to suppress cutaneous inflammation, pruritus, and immune signaling, while triclosan provides local antibacterial activity. The combination is used for corticosteroid-responsive inflammatory dermatoses complicated by, or prone to, superficial bacterial infection, including acute infected eczema and atopic dermatitis. Marketed products include Sicorten Plus and the Chinese product 新适确得.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on halometasone + triclosan.